In a year marked by significant revenue declines for major players in the mRNA and COVID-19 vaccine space, BioNTech SE...

In a stark demonstration of strategic realignment, Oracle unveiled two major developments this week that highlight its aggressive pivot towards...

Take-Two Interactive has closed its books on fiscal year 2026, with investor focus now squarely fixed on the horizon. The...

In a rare admission, legendary investor Warren Buffett conceded to a significant error in judgment regarding his stake in Apple...

The independent Texas-based oil producer Battalion Oil is advancing a dual strategy to strengthen its financial foundation and sharpen its...

After a period of significant market volatility, Teradyne is once again commanding attention from Wall Street analysts. The semiconductor equipment...

Market experts are growing more optimistic about Cardiff Oncology's financial trajectory. Following the biotechnology firm's stronger-than-anticipated performance in February, analysts...

Vivani Medical finds itself balancing promising clinical developments against financial market realities. The biotechnology firm is targeting the high-growth weight-loss...

Despite announcing record annual revenues and a substantial order backlog, shares in the Czechoslovak Group (CSG) have been under significant...

Roche has secured significant regulatory approvals across two major markets, delivering a strategic boost to its high-margin diagnostics business. The...